John B. Sunwoo
Publications
- Epigenetically mediated pathogenic effects of phenanthrene on regulatory T cells. J Toxicol. 2013: 967029
- Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. Cancer. 2013; (7): 1349-56
- Targeted endoscopic salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma. Int Forum Allergy Rhinol. 2012 Mar-Apr; (2): 166-73
- CD44(+) cells have cancer stem cell-like properties in nasopharyngeal carcinoma. Int Forum Allergy Rhinol. 2012; (6): 465-70
- ERK1/2 regulation of CD44 modulates oral cancer aggressiveness. Cancer Res. 2012; (1): 365-74
- Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions. Int Immunol. 2012; (12): 793-802
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci U S A. 2012; (17): 6662-7
- The manipulation of natural killer cells to target tumor sites using magnetic nanoparticles. Biomaterials. 2012; (22): 5584-92
- A cisplatin-resistant subpopulation of mesenchymal-like cells in head and neck squamous cell carcinoma. Cell Cycle. 2011; (17): 2834-5
- Distal-less homeobox transcription factors regulate development and maturation of natural killer cells. Proc Natl Acad Sci U S A. 2008; (31): 10877-82
- HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci U S A. 2008; (8): 3053-8
- Spontaneous regression of cutaneous head and neck melanoma: implications for the immunologic control of neoplasia. Head Neck. 2008; (2): 267-72
- Temporal relationship between antitumor necrosis factor-alpha antibody therapy and recrudescence of head and neck squamous cell carcinoma. Laryngoscope. 2008; (3): 450-2
- Mycotic pseudoaneurysm of the internal maxillary artery: case report and review of the literature. Arch Otolaryngol Head Neck Surg. 2007; (4): 402-6
- Arrested natural killer cell development associated with transgene insertion into the Atf2 locus. Blood. 2006; (3): 1024-30
- Inhibition of nuclear factor-kappaB and target genes during combined therapy with proteasome inhibitor bortezomib and reirradiation in patients with recurrent head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2005; (5): 1400-12
- Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005; (7051): 709-13
- Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res. 2004; (18): 6511-23
- Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer. 2002; (4): 538-48
- Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. Clin Cancer Res. 2001; (2): 435-42
- Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer. J Clin Oncol. 2001; (3): 800-11
- IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res. 2001; (6): 1812-20
- Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin Cancer Res. 2001; (5): 1419-28
- Transcript map of the 8p23 putative tumor suppressor region. Genomics. 2001; (1-3): 17-25
- Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Mol Carcinog. 1999; (2): 119-29
- Homozygous deletions define a region of 8p23.2 containing a putative tumor suppressor gene. Genomics. 1999; (2): 184-8
- Localization of a putative tumor suppressor gene in the sub-telomeric region of chromosome 8p. Oncogene. 1999; (16): 2651-5
- Multiple regions of deletion on chromosome arm 13q in head-and-neck squamous-cell carcinoma. Int J Cancer. 1999; (5): 453-7
- Clinical correlations with allelotype in supraglottic squamous cancer. Otolaryngol Head Neck Surg. 1998; (3 Pt 1): 363-70
- Chromosome 8 allelic loss and the outcome of patients with squamous cell carcinoma of the supraglottic larynx. J Natl Cancer Inst. 1996; (22): 1676-82
- Evidence for multiple tumor suppressor genes on chromosome arm 8p in supraglottic laryngeal cancer. Genes Chromosomes Cancer. 1996; (3): 164-9
- Cell cycle oscillation of phosphatase inhibitor-2 in rat fibroblasts coincident with p34cdc2 restriction. Nature. 1990; (6261): 74-8

